Treating Breast Cancer in the Era of Targeted Therapy

CME
This program focuses on discussion of the wide range of options available for first and subsequent lines of therapy in the treatment of breast cancer.
Duration
December 18, 2009 to December 18, 2010
Credits
Maximum of 3.0 AMA PRA Category 1 Credits™
Faculty
Paul Goss, MD, PhD, FRCPC, FRCP | Paula D. Ryan, MD, PhD | Jack Erban, MD | Steven Isakoff, MD | Beverly Moy, MD, MPH

This course is not part of OncologySTAT.
By clicking the button below you will be leaving this website.


Community CommentsTotal comments to date:

Program accredited by:

The joint sponsorship of Beth Israel Medical Center, St. Luke's and Roosevelt Hospitals, Massachusetts General Hospital Academy and Reed Medical Education.

Program supported by:

Our evidence-based curriculum is supported by an educational grant from Genentech, sanofi-aventis, and Bristol-Myers Squibb

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration